Insider Transactions in Q1 2022 at Kinnate Biopharma Inc. (KNTE)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Richard Thomas Williams CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
25,000
+37.13%
|
$200,000
$8.37 P/Share
|
|
Mar 11
2022
|
Richard Thomas Williams CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
15,000
+46.39%
|
$120,000
$8.64 P/Share
|
|
Feb 15
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
9,000
+0.26%
|
$81,000
$9.96 P/Share
|
|
Feb 15
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
9,000
+0.26%
|
$81,000
$9.96 P/Share
|
|
Feb 14
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
30,700
+0.44%
|
$276,300
$9.94 P/Share
|
|
Feb 14
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
30,700
+0.44%
|
$276,300
$9.94 P/Share
|
|
Feb 11
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
156,000
+4.3%
|
$1,560,000
$10.22 P/Share
|
|
Feb 11
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
156,000
+4.3%
|
$1,560,000
$10.22 P/Share
|